Breaking news from the #CDC today:

The agency has updated the childhood vaccine schedule, reducing the number of vaccines recommended for all children and shifting others to risk-based or shared decision-making categories.

MORE: www.contemporarypediatrics.com/view/cdc-cha...

A new Special Report, "Advances in Type 1 Diabetes Management," is now free to watch on Contemporary Pediatrics!

In this 6-part series, Herbert Bravo MD, and Marian Rewers, MD, PhD, discuss the latest #T1D developments.

Click here for the full series:
www.contemporarypediatrics.com/video-series...

In this short video, Mimi C. Lee, MD, PhD, explains the mechanism of whole genome and exome testing, highlighting GeneDx's ExomeDx test and GenomeDx tests. #medsky

Watch the full interview with Lee, and learn more about genetic testing: www.contemporarypediatrics.com/view/mimi-c-...

Angela Hasler, RN, MSN, CPNP-PC, expresses excitement for the December 11, 2025, FDA approval of GSK's gepotidacin, indicated to treat uncomplicated urogenital #gonorrhea in patients aged 12 years and older weighing at least 45 kg. #medsky

MORE: www.contemporarypediatrics.com/view/the-ben...

Edward Hook, MD, reacts to the FDA approval of zoliflodacin for uncomplicated urogenital gonorrhea | Contemporary Pediatrics “Having a drug that [patients] can be confident in that will be highly effective as well as well tolerated is a great advantage," said Edward Hook, MD.

Edward Hook, MD, emeritus professor of Medicine, University of Alabama at Birmingham, emphasized the importance of today's zoliflodacin #FDA approval to treat for the treatment of uncomplicated urogenital #gonorrhea.

Watch the full interview: www.contemporarypediatrics.com/view/edward-...

The FDA has approved BioCryst Pharmaceuticals, Inc.'s berotralstat (#ORLADEYO) prophylactic oral pellets for pediatric patients aged 2 to <12 years with HAE.

Berotralstat is now the first targeted oral prophylactic for this indication.

FULL DETAILS: www.contemporarypediatrics.com/view/fda-app...

Breaking #FDA news:

The federal agency has approved GSK's gepotidacin (Blujepa) as an oral option to treat uncomplicated urogenital #gonorrhea in patients aged 12 years and older weighing at least 45 kg.

Full details: www.contemporarypediatrics.com/view/fda-app...

If you missed it:

The FDA is launching a safety review of #RSV preventive monoclonal antibodies #nirsevimab and #clesrovimab. Reuters reported that FDA officials made inquiries into the RSV preventive therapies in the summer. #medsky

Full details: www.contemporarypediatrics.com/view/reports...

Thank you for sharing!

In light of today's #ACIP meeting, Chari Cohen, DrPH, MPH, president of the Hepatitis B Foundation, explains that the foundation is recommending that #infants continue to receive the birth dose of the hepatitis B #vaccine.

Watch:
www.contemporarypediatrics.com/view/hepatit...

NEW TODAY:

The Centers for Disease Control and Prevention's ACIP has voted to pass a pair of updated recommendations related to the #hepatitis B virus vaccine and timing among infants.

View the exact voting language and how the committee voted, here: www.contemporarypediatrics.com/view/acip-vo...

Josh Feder, MD, explains applied behavioral analysis, part of a larger discussion of the recent recommendations from the American Academy of Child and Adolescent Psychiatry (@AACAP) to improve and expand access to #autism care.
Watch the full interview: www.contemporarypediatrics.com/view/joshua-...

The open-label trial will assess safety, tolerability, pharmacodynamics, and preliminary efficacy in adults before expanding into a pediatric cohort.

#Pediatrics #Immunology #RareDisease #GeneTherapy

READ MORE: www.contemporarypediatrics.com/view/first-p...

In our latest #puzzler quiz, try to diagnose this 8-year-old girl with a corneal lesion.

View some case details below, then click the link for more information and to make your diagnosis.

Can you diagnose this patient?

View more: www.contemporarypediatrics.com/view/can-you...

FDA accepts roflumilast cream 0.3% sNDA to treat plaque psoriasis in children 2 to 5 years | Contemporary Pediatrics The target action date for roflumilast cream 0.3% for plaque psoriasis in children 2 to 5 years is set for June 29, 2026.

FULL DETAILS: www.contemporarypediatrics.com/view/fda-acc...

New from the FDA:

The agency accepts Arcutis Biotherapeutics' sNDA application for #roflumilast cream 0.3% (Zoryve) to treat #plaque #psoriasis in children aged 2 to 5 years. #medsky #pedsky

More details to come on contemporarypediatrics.com.

J&J submits sBLA for ustekinumab to treat children with ulcerative colitis 2 years and up | Contemporary Pediatrics If approved, this UC indication would add to pediatric indications of ustekinumab for psoriasis and active psoriatic arthritis.

ICYMI:

J&J has submitted a supplemental Biologics License Application to the FDA for ustekinumab (Stelara), seeking an expanded indication to include children 2 years and older with moderately-to-severely active ulcerative colitis. #pedksy

DETAILS: www.contemporarypediatrics.com/view/j-j-sub...

Arcutis Biotherapeutics has announced the commercial launch of #roflumilast 0.05% for the treatment of mild-to-moderate atopic dermatitis in children aged 2 to 5 years.

Arcutis stated the topical formulation will be available in pharmacies this week.

www.contemporarypediatrics.com/view/lawrenc...

Upadacitinib achieves 50% reduction in Total Vitiligo Area Scoring Index at 48 weeks A pair of phase 3 trials showed that AbbVie's daily upadacitinib 15 mg led to a 50% reduction in T-VASI 50 and a 75% reduction in F-VASI 75 at 48 weeks among adolescents 12 years and older.

According to new phase 3 data, #upadacitinib met co-primary endpoints in both Phase 3 trials for non-segmental #vitiligo at week 48, among adults and adolescents. #medsky #pedsky

Full details: www.contemporarypediatrics.com/view/upadaci...

Talking ticks with Tracey Gaslin, PhD, CPNP, FNP-BC, CRNI, RN-BC In this Q&A, nurse practitioner Tracey Gaslin, PhD, discusses tick bites in pediatric patients, from how to prevent a bite to what to do after a bite, and highlights resources available from the Fight...

In this Q&A, Tracey Gaslin PhD, CPNP, FNP-BC, CRNI, RN-BC, of Alliance for Camp Health, talks about #ticks!
Highlights:

- Extended tick activity later into the year

- How pediatricians can educate families on ticks, bites, and post-bite care

Read: www.contemporarypediatrics.com/view/talking...

In this Q&A discussion, study investigator of zoliflodacin, Sarah McLeod, PhD, highlights phase 3 data on the drug's efficacy against multidrug-resistant Neisseria #gonorrhoeae. #IDWeek #medsky #pedsky

Click here to read this Q&A from #IDWeek:
www.contemporarypediatrics.com/view/sarah-m...

Also new today out of #FallClinical2025 in Vegas:

Lebrikizumab-lbkz (Ebglyss; EliLillyandCo) demonstrated similar levels of #skin clearance in patients with #atopicdermatitis when administered once every 8 weeks compared to every 4 weeks.

MORE: www.contemporarypediatrics.com/view/fall-cl...

Announced at the 2025 @fallclinical #Dermatology Conference in Las Vegas:

Roflumilast cream 0.15% and 0.05% demonstrated improved #itch and reduced impact of AD on sleep in patients 2 years and up. #medsky #pedsky

Full coverage: www.contemporarypediatrics.com/view/fall-cl...

FDA expands adalimumab-aaty's pediatric indications to include hidradenitis suppurativa, uveitis Indication expansions include hidradenitis suppurativa for patients 12 years and up, as well as for patients with uveitis aged 2 years and older.

For full approval details, read our full article: www.contemporarypediatrics.com/view/fda-exp...

#medsky #pedsky

The #FDA has expanded pediatric indications for adalimumab-aaty (Yuflyma; Celltrion USA) and unbranded adalimumab-aaty to include the treatment of hidradenitis suppurativa in adolescent patients aged 12 years and older, and uveitis in pediatric patients aged 2 years and older.

IDSA recommends use of scoring systems to guide testing for Group A Streptococcal pharyngitis IDSA’s new GAS pharyngitis guidance emphasizes selective testing using clinical scoring to reduce overtreatment and antibiotic misuse.

This week, the Infectious Diseases Society of America released updated guidelines regarding testing for Group A Streptococcal pharyngitis in adolescents and adults. #Strep #Strepthroat #medksy #pediatrics #pedsky

Read more on the updated guideline: www.contemporarypediatrics.com/view/idsa-re...

Thank you, peace madueme, MD, chief of #Cardiology at @Nemours Children's Hospital in Orlando, Florida, for speaking with us about #ECGs and how they can supplement routine sports physicals for #youth athletes. #medsky

Watch our full interview here: www.contemporarypediatrics.com/view/using-e...

If you missed it:

Today, the FDA accepted MannKind Corporation's sBLA for #Afrezza Inhalation Powder to include children and adolescents with type 1 or type 2 #diabetes.

READ MORE:
www.contemporarypediatrics.com/view/fda-acc...

Backup camera mandate linked to fewer severe pediatric backover injuries: Backover trauma occurs when a pedestrian is struck by a motor vehicle in reverse. Researchers reported both fatal and severe injuries in children under age 5 have decreased. #medsky #pedsky

More:
hubs.li/Q03LwvXw0

The study, "The Association of Maternal Adverse Childhood Experiences with Preterm Birth of Their Infants," found that #mothers with 2 or more ACEs were nearly twice as likely to deliver #preterm as those with fewer or no ACEs.

Read more: hubs.li/Q03Lwwht0